These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 36064448)

  • 1. Overestimation of benefit when clinical trials stop early: a simulation study.
    Liu S; Garrison SR
    Trials; 2022 Sep; 23(1):747. PubMed ID: 36064448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized trials stopped early for benefit: a systematic review.
    Montori VM; Devereaux PJ; Adhikari NK; Burns KE; Eggert CH; Briel M; Lacchetti C; Leung TW; Darling E; Bryant DM; Bucher HC; Schünemann HJ; Meade MO; Cook DJ; Erwin PJ; Sood A; Sood R; Lo B; Thompson CA; Zhou Q; Mills E; Guyatt GH
    JAMA; 2005 Nov; 294(17):2203-9. PubMed ID: 16264162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantifying over-estimation in early stopped clinical trials and the "freezing effect" on subsequent research.
    Wang H; Rosner GL; Goodman SN
    Clin Trials; 2016 Dec; 13(6):621-631. PubMed ID: 27271682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stopping randomized trials early for benefit: a protocol of the Study Of Trial Policy Of Interim Truncation-2 (STOPIT-2).
    Briel M; Lane M; Montori VM; Bassler D; Glasziou P; Malaga G; Akl EA; Ferreira-Gonzalez I; Alonso-Coello P; Urrutia G; Kunz R; Culebro CR; da Silva SA; Flynn DN; Elamin MB; Strahm B; Murad MH; Djulbegovic B; Adhikari NK; Mills EJ; Gwadry-Sridhar F; Kirpalani H; Soares HP; Abu Elnour NO; You JJ; Karanicolas PJ; Bucher HC; Lampropulos JF; Nordmann AJ; Burns KE; Mulla SM; Raatz H; Sood A; Kaur J; Bankhead CR; Mullan RJ; Nerenberg KA; Vandvik PO; Coto-Yglesias F; Schünemann H; Tuche F; Chrispim PP; Cook DJ; Lutz K; Ribic CM; Vale N; Erwin PJ; Perera R; Zhou Q; Heels-Ansdell D; Ramsay T; Walter SD; Guyatt GH
    Trials; 2009 Jul; 10():49. PubMed ID: 19580665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reducing overestimation of the treatment effect by interim analysis when designing clinical trials.
    Shimura M
    J Clin Pharm Ther; 2019 Apr; 44(2):243-248. PubMed ID: 30414384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantifying the bias in the estimated treatment effect in randomized trials having interim analyses and a rule for early stopping for futility.
    Walter SD; Han H; Briel M; Guyatt GH
    Stat Med; 2017 Apr; 36(9):1506-1518. PubMed ID: 28183155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stopping clinical trials early for benefit: impact on estimation.
    Freidlin B; Korn EL
    Clin Trials; 2009 Apr; 6(2):119-25. PubMed ID: 19342463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meta-analysis of clinical trials with early stopping: an investigation of potential bias.
    Schou IM; Marschner IC
    Stat Med; 2013 Dec; 32(28):4859-74. PubMed ID: 23824994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stopping randomized trials early for benefit and estimation of treatment effects: systematic review and meta-regression analysis.
    Bassler D; Briel M; Montori VM; Lane M; Glasziou P; Zhou Q; Heels-Ansdell D; Walter SD; Guyatt GH; ; Flynn DN; Elamin MB; Murad MH; Abu Elnour NO; Lampropulos JF; Sood A; Mullan RJ; Erwin PJ; Bankhead CR; Perera R; Ruiz Culebro C; You JJ; Mulla SM; Kaur J; Nerenberg KA; Schünemann H; Cook DJ; Lutz K; Ribic CM; Vale N; Malaga G; Akl EA; Ferreira-Gonzalez I; Alonso-Coello P; Urrutia G; Kunz R; Bucher HC; Nordmann AJ; Raatz H; da Silva SA; Tuche F; Strahm B; Djulbegovic B; Adhikari NK; Mills EJ; Gwadry-Sridhar F; Kirpalani H; Soares HP; Karanicolas PJ; Burns KE; Vandvik PO; Coto-Yglesias F; Chrispim PP; Ramsay T
    JAMA; 2010 Mar; 303(12):1180-7. PubMed ID: 20332404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomised trials with provision for early stopping for benefit (or harm): The impact on the estimated treatment effect.
    Walter SD; Guyatt GH; Bassler D; Briel M; Ramsay T; Han HD
    Stat Med; 2019 Jun; 38(14):2524-2543. PubMed ID: 30887553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A systematic survey of randomised trials that stopped early for reasons of futility.
    Walter SD; Han H; Guyatt GH; Bassler D; Bhatnagar N; Gloy V; Schandelmaier S; Briel M
    BMC Med Res Methodol; 2020 Jan; 20(1):10. PubMed ID: 31948397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The number of patients and events required to limit the risk of overestimation of intervention effects in meta-analysis--a simulation study.
    Thorlund K; Imberger G; Walsh M; Chu R; Gluud C; Wetterslev J; Guyatt G; Devereaux PJ; Thabane L
    PLoS One; 2011; 6(10):e25491. PubMed ID: 22028777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early stopping of randomized clinical trials for overt efficacy is problematic.
    Bassler D; Montori VM; Briel M; Glasziou P; Guyatt G
    J Clin Epidemiol; 2008 Mar; 61(3):241-6. PubMed ID: 18226746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of lack-of-benefit stopping rules on treatment effect estimates of two-arm multi-stage (TAMS) trials with time to event outcome.
    Choodari-Oskooei B; Parmar MK; Royston P; Bowden J
    Trials; 2013 Jan; 14():23. PubMed ID: 23343147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A group sequential, response-adaptive design for randomized clinical trials.
    Karrison TG; Huo D; Chappell R
    Control Clin Trials; 2003 Oct; 24(5):506-22. PubMed ID: 14500050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing the impact of efficacy stopping rules on the error rates under the multi-arm multi-stage framework.
    Blenkinsop A; Parmar MK; Choodari-Oskooei B
    Clin Trials; 2019 Apr; 16(2):132-141. PubMed ID: 30648428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bayesian Interim Analysis and Efficiency of Phase III Randomized Trials.
    Sherry AD; Msaouel P; Miller AM; Lin TA; Kupferman GS; Jaoude JA; Kouzy R; El-Alam MB; Patel R; Koong A; Lin C; Meirson T; McCaw ZR; Ludmir EB
    medRxiv; 2024 Jun; ():. PubMed ID: 38978666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. When inferiority meets non-inferiority: implications for interim analyses.
    Bratton DJ; Williams HC; Kahan BC; Phillips PP; Nunn AJ
    Clin Trials; 2012 Oct; 9(5):605-9. PubMed ID: 22796636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized trials addressing a similar question are commonly published after a trial stopped early for benefit.
    Murad MH; Guyatt GH; Domecq JP; Vernooij RWM; Erwin PJ; Meerpohl JJ; Prutsky GJ; Akl EA; Mueller K; Bassler D; Schandelmaier S; Walter SD; Busse JW; Kasenda B; Pagano G; Pardo-Hernandez H; Montori VM; Wang Z; Briel M
    J Clin Epidemiol; 2017 Feb; 82():12-19. PubMed ID: 27832953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ethical issues in stopping randomized trials early because of apparent benefit.
    Mueller PS; Montori VM; Bassler D; Koenig BA; Guyatt GH
    Ann Intern Med; 2007 Jun; 146(12):878-81. PubMed ID: 17577007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.